TY  - GEN
AU  - Morel,O
AU  - Hugel,B
AU  - Jesel,L
AU  - Mallat,Z
AU  - Lanza,F
AU  - Douchet,M-P
AU  - Zupan,M
AU  - Chauvin,M
AU  - Cazenave,J-P
AU  - Tedgui,A
AU  - Freyssinet,J-M
AU  - Toti,F
TI  - Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists
SN  - 1538-7933
PY  - 2005///0302
KW  - Abciximab
KW  - Adrenergic beta-Antagonists
KW  - therapeutic use
KW  - Adult
KW  - Aged
KW  - Angioplasty, Balloon, Coronary
KW  - adverse effects
KW  - Antibodies, Monoclonal
KW  - pharmacology
KW  - Aspirin
KW  - Biomarkers
KW  - blood
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - Particle Size
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Platelet Glycoprotein GPIb-IX Complex
KW  - analysis
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Solubility
KW  - Thrombophilia
KW  - diagnosis
N1  - Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
UR  - https://doi.org/10.1111/j.1538-7836.2004.00805.x
ER  -